On November 11th, 2024 Alberto Arzenton from cycle 37 successfully defended his PhD thesis on “Towards 111Ag as a medical radionuclide: from production and laser photo-ionisation to cell dosimetry and radiation biophysics in the context of the ISOLPHARM project”.
Congratulations Alberto!
